Alameda, Josefa P.Fernández Aceñero, María JesúsMoreno Maldonado, RodolfoNavarro, ManuelQuintana, R.Page, AngustiasRamírez, ÁngelBravo Moral, Ana MaríaLlanos Casanova, M.2020-05-142020-05-142011Alameda, J. P., Fernandez-Acenero, M. J., Moreno-Maldonado, R., Navarro, M., Quintana, R., Page, A., ... & Casanova, M. L. (2011). CYLD regulates keratinocyte differentiation and skin cancer progression in humans. Cell death & disease, 2(9), e208-e208.http://hdl.handle.net/10347/22318CYLD is a gene mutated in familial cylindromatosis and related diseases, leading to the development of skin appendages tumors. Although the deubiquitinase CYLD is a skin tumor suppressor, its role in skin physiology is unknown. Using skin organotypic cultures as experimental model to mimic human skin, we have found that CYLD acts as a regulator of epidermal differentiation in humans through the JNK signaling pathway. We have determined the requirement of CYLD for the maintenance of epidermal polarity, keratinocyte differentiation and apoptosis. We show that CYLD overexpression increases keratinocyte differentiation while CYLD loss of function impairs epidermal differentiation. In addition, we describe the important role of CYLD in the control of human non-melanoma skin cancer progression. Our results show the reversion of the malignancy of human squamous cell carcinomas that express increased levels of CYLD, while its functional inhibition enhances the aggressiveness of these tumors which progress toward spindle cell carcinomas. We have found that the mechanisms through which CYLD regulates skin cancer progression include the control of tumor differentiation, angiogenesis and cell survival. These findings of the role of CYLD in human skin cancer prognosis make our results relevant from a therapeutic point of view, and open new avenues for exploring novel cancer therapieseng© 2011 Macmillan Publishers Limited. This work is licensed under the Creative Commons Attribution-NonCommercial-No Derivative Works 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/3.0/http://creativecommons.org/licenses/by-nc-nd/3.0/CYLDKeratinocyte differentiationSkin cancerSkin equivalentsjournal article10.1038/cddis.2011.822041-4889open access